CHARACTERIZATION OF STEREOISOMERISM OF ANTISENSE OLIGONUCLEOTIDES

被引:0
|
作者
TAMURA, Y
UEMATSU, H
MIYOSHI, H
MAKINO, K
MURAKAMI, A
机构
关键词
D O I
10.1246/nikkashi.1995.588
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Antisense strategy is one of the promising methods for curing incurable diseases such as cancer and AIDS by regulating gene expression. Oligonucleotides and their analogs have been innovated and used for the purposes. However, stereoisomerism of antisense molecules that intrinsically exists in such molecules contains a crucial problem for the future development of the strategy. In this report, the effects of stereoisomerism on antisense effects were studied by reversed phase HPLC, UV and CD spectroscopy. As antisense molecules, oligonucleoside phosphoramidates and oligonucleoside phosphorothioates both of which contain stereoisomeric modified phosphate linkages, were synthesized and characterized. As results, it was found that there exist large differences in solution structure and that the stereoisomerism may have crucial effect on the antisense gene regulation.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 50 条
  • [31] MEETING REPORT - ANTISENSE OLIGONUCLEOTIDES
    MARTINELLI, G
    FERRARI, S
    HAEMATOLOGICA, 1994, 79 (02) : 184 - 188
  • [32] Antisense oligonucleotides for the treatment of dyslipidaemia
    Visser, Maartje E.
    Witztum, Joseph L.
    Stroes, Erik S. G.
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1451 - 1458
  • [33] IMMUNOMODULATION BY CYTOKINE ANTISENSE OLIGONUCLEOTIDES
    DHELLENCOURT, CL
    DIAW, L
    GUENOUNOU, M
    EUROPEAN CYTOKINE NETWORK, 1995, 6 (01) : 7 - 19
  • [34] ANTISENSE OLIGONUCLEOTIDES AS ANTIVIRAL AGENTS
    AGRAWAL, S
    TRENDS IN BIOTECHNOLOGY, 1992, 10 (05) : 152 - 158
  • [35] Antisense oligonucleotides for atherosclerotic disease
    Bajaj, Archna
    Rader, Daniel J.
    NATURE MEDICINE, 2020, 26 (04) : 471 - 472
  • [36] Antisense Oligonucleotides Targeting Lipoprotein(a)
    Langsted, Anne
    Nordestgaard, Borge G.
    CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (08)
  • [37] Antisense oligonucleotides as therapeutic agents
    Alama, A
    Barbieri, F
    Cagnoli, M
    Schettini, G
    PHARMACOLOGICAL RESEARCH, 1997, 36 (03) : 171 - 178
  • [38] Cellular delivery of antisense oligonucleotides
    Lebedeva, I
    Benimetskaya, L
    Stein, CA
    Vilenchik, M
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 101 - 119
  • [39] THE SENSE OF ANTISENSE FOS OLIGONUCLEOTIDES
    SHARP, FR
    ANNALS OF NEUROLOGY, 1994, 36 (04) : 555 - 556
  • [40] The disposition (ADME) of antisense oligonucleotides
    Dvorchik, BH
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2000, 2 (03) : 253 - 257